NASDAQ
31.12.25 | 21:58
23,310 US-Dollar
-2,06 % -0,490
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.12.25 | Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic | 100 | GlobeNewswire (Europe) | Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic's granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara... ► Artikel lesen | |
| 26.11.25 | Sanara MedTech Inc. - 8-K, Current Report | - | SEC Filings | ||
| SANARA MEDTECH Aktie jetzt für 0€ handeln | |||||
| 12.11.25 | Sanara MedTech Inc. - 10-Q, Quarterly Report | 8 | SEC Filings | ||
| 12.11.25 | Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus | 3 | Seeking Alpha | ||
| 12.11.25 | Sanara MedTech GAAP EPS of $0.09 beats by $0.30, revenue of $26.3M misses by $0.33M | 4 | Seeking Alpha | ||
| 12.11.25 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.11.25 | Sanara MedTech discontinues Tissue Health Plus segment | 2 | Investing.com | ||
| 11.11.25 | Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business | 111 | GlobeNewswire (Europe) | Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us")... ► Artikel lesen | |
| 03.09.25 | Sanara MedTech stock falls after CEO succession announcement | 1 | Investing.com | ||
| 02.09.25 | Sanara MedTech appoints new CEO | 2 | Seeking Alpha | ||
| 02.09.25 | Sanara MedTech appoints Seth Yon as new CEO effective Sept 15 | 1 | Investing.com | ||
| 02.09.25 | Führungswechsel bei Sanara MedTech: Seth Yon wird neuer CEO | 1 | Investing.com Deutsch | ||
| 02.09.25 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.09.25 | Sanara MedTech Inc. Announces Chief Executive Officer Transition | 156 | GlobeNewswire (Europe) | Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company... ► Artikel lesen | |
| 13.08.25 | Sanara MedTech Inc. - 10-Q, Quarterly Report | 8 | SEC Filings | ||
| 13.08.25 | Sanara MedTech reports Q2 results | 3 | Seeking Alpha | ||
| 13.08.25 | Sanara MedTech Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 15.07.25 | Sanara MedTech Inc.: Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025 | 2 | GlobeNewswire (USA) | ||
| 15.07.25 | Sanara MedTech: Cantor Fitzgerald bestätigt "Overweight"-Rating nach Start von Pilotprogramm | 1 | Investing.com Deutsch | ||
| 15.07.25 | Sanara MedTech stock maintains Overweight rating at Cantor Fitzgerald | 1 | Investing.com |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS | 9,530 | 0,00 % | Intelligent Bio Solutions launches $10M private placement | ||
| BETA BIONICS | 30,470 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 130,06 | +1,61 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| HEARTFLOW | 29,150 | -3,51 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,760 | +2,70 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,170 | -2,62 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| SIGHT SCIENCES | 7,930 | -0,88 % | Sight Sciences, Inc.: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,450 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| OPTIMIZERX | 12,260 | -1,05 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
| CERIBELL | 21,930 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| EKSO BIONICS | 8,640 | 0,00 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,460 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| RXSIGHT | 10,420 | 0,00 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| PROGYNY | 25,690 | -0,58 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BILLIONTOONE | 81,73 | -3,95 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
Das Unternehmen SANARA MEDTECH INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,490 (-2,06 %) liegt der Kurs bei 23,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANARA MEDTECH INC finden Sie auf Wallstreet Online.